According to Pacific Biosciences
's latest financial reports the company has $0.70 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.70 B | 24.59% |
2022-12-31 | $0.56 B | -28.84% |
2021-12-31 | $0.79 B | 135.77% |
2020-12-31 | $0.33 B | 510.91% |
2019-12-31 | $54.91 M | -51.85% |
2018-12-31 | $0.11 B | 32.47% |
2017-12-31 | $86.1 M | 1.69% |
2016-12-31 | $84.66 M | 15.13% |
2015-12-31 | $73.54 M | 33.83% |
2014-12-31 | $54.94 M | -20.57% |
2013-12-31 | $69.18 M | -36.75% |
2012-12-31 | $0.10 B | -42.87% |
2011-12-31 | $0.19 B | -31.59% |
2010-12-31 | $0.27 B | -258.01% |
2009-12-31 | $-0.18 B | 89.66% |
2008-12-31 | $-93.39 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $46.84 B | 6,579.27% | ๐บ๐ธ USA |
General Electric GE | $28.58 B | 3,975.27% | ๐บ๐ธ USA |
Illumina ILMN | $5.74 B | 719.19% | ๐บ๐ธ USA |
PerkinElmer
PKI | $8.03 B | 1,045.55% | ๐บ๐ธ USA |
NanoString Technologies NSTG | -$50.57 M | -107.21% | ๐บ๐ธ USA |